These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7864838)

  • 1. Evidence for a ligand receptor system mediating the biologic effects of glycated albumin in glomerular mesangial cells.
    Wu VY; Cohen MP
    Biochem Biophys Res Commun; 1995 Feb; 207(2):521-8. PubMed ID: 7864838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
    Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP
    Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.
    Ziyadeh FN; Cohen MP
    Mol Cell Biochem; 1993 Aug; 125(1):19-25. PubMed ID: 8264568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors specific for Amadori-modified glycated albumin on murine endothelial cells.
    Wu VY; Cohen MP
    Biochem Biophys Res Commun; 1994 Jan; 198(2):734-9. PubMed ID: 7507669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription.
    Cohen MP; Hud E; Wu VY; Ziyadeh FN
    Mol Cell Biochem; 1995 Oct; 151(1):61-7. PubMed ID: 8584015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells.
    Cohen MP; Ziyadeh FN; Lautenslager GT; Cohen JA; Shearman CW
    Am J Physiol; 1999 May; 276(5):F684-90. PubMed ID: 10330050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression.
    Cohen MP; Ziyadeh FN
    Kidney Int; 1994 Feb; 45(2):475-84. PubMed ID: 8164436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of calnexin as a binding protein for Amadori-modified glycated albumin.
    Wu VY; Shearman CW; Cohen MP
    Biochem Biophys Res Commun; 2001 Jun; 284(3):602-6. PubMed ID: 11396943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycated albumin stimulates fibronectin and collagen IV production by glomerular endothelial cells under normoglycemic conditions.
    Cohen MP; Wu VY; Cohen JA
    Biochem Biophys Res Commun; 1997 Oct; 239(1):91-4. PubMed ID: 9345275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK mediates effects of glycated albumin in mesangial cells.
    Cohen MP; Shea E; Shearman CW
    Biochem Biophys Res Commun; 2001 May; 283(3):641-3. PubMed ID: 11341772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biology.
    Cohen MP; Hud E; Wu VY; Ziyadeh FN
    Mol Cell Biochem; 1995 Feb; 143(1):73-9. PubMed ID: 7776962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
    Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
    Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
    J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
    Cohen MP; Hud E; Wu VY
    Kidney Int; 1994 Jun; 45(6):1673-9. PubMed ID: 7933815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated albumin induces superoxide generation in mesangial cells.
    Yoo CW; Song CY; Kim BC; Hong HK; Lee HS
    Cell Physiol Biochem; 2004; 14(4-6):361-8. PubMed ID: 15319540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of aortic endothelial cell binding proteins for Amadori adducts in glycated albumin.
    Wu VY; Cohen MP
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1131-6. PubMed ID: 8323537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.
    Skolnik EY; Yang Z; Makita Z; Radoff S; Kirstein M; Vlassara H
    J Exp Med; 1991 Oct; 174(4):931-9. PubMed ID: 1655949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
    Cohen MP; Ziyadeh FN
    J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
    Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
    Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells.
    Chen S; Cohen MP; Lautenslager GT; Shearman CW; Ziyadeh FN
    Kidney Int; 2001 Feb; 59(2):673-81. PubMed ID: 11168949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.